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Abstract 
Degradation of extracellular matrix proteins is performed by metalloproteinases which are inhibited by tissue inhibitors of metalloproteinases 
(TIMP). We expressed the murine TIMP-I protein in E. coli and prepared a polyclonal antiserum against the recombinant protein. Using this 
antiserum we studied the biosynthesis and glycosylation of murine TIMP-I protein in COS-7 cells transfected with a TIMP-1 expression plasmid 
by metabolic labeling and indirect immunofluorescence studies. In primary rat hepatocytes we show for the first time that TIMP-1 protein expression 
is up-regulated upon stimulation with IL-lp and IL-6. Since TIMP-I is induced during the acute phase reaction it could possibly be involved in the 
pathogenesis of liver fibrosis. 
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1. Introduction 
Alterations in the balance between synthesis and deg- 
radation of extracellular matrix may result in tissue scle- 
rosis and fibrosis. The interaction between metallopro- 
teinases and their inhibitors modulates the rate of matrix 
degradation and accumulation for example in glomeru- 
losclerosis [I] or liver fibrosis [2] as well as in rapid 
matrix destruction occuring during arthritis (for review 
see [3-51). Furthermore it is widely accepted that col- 
lagenolytic enzymes and their inhibitors are involved in 
the invasion and spread of tumor cells into host tissues 
[6,7]. In some cell lines, however, TIMP-1 has the prop- 
erties of a tumor-suppressor gene or anti-oncogene [8,9]. 
Murine TIMP-I is a secreted glycoprotein of 184 
amino acids (I& = 28 kDa) with a high sequence identity 
to rat and human TIMP-1 [IO]. By forming a tight com- 
plex of 1: 1 stoichiometry with the target matrix metal- 
loproteinases, TIMP-1 regulates the breakdown of colla- 
gen and basement membrane components [11,12]. In 
murine fibroblast cells the expression of TIMP-1 mRNA 
is induced by serum, 4p-phorbol-12-myristate- 13-ace- 
tate, fibroblast growth factor and platelet derived growth 
factor [13-l 51. Oncostatin M, Interleukin-6 (IL-6), leu- 
kemia inhibitory factor (LIF), and IL-la elevate the 
TIMP-1 expression at the RNA level in human lung 
fibroblasts [16]. In previous reports we demonstrated 
that TIMP-1 mRNA is up-regulated in hepatic cells by 
inflammatory cytokines such as IL- 1, IL-6, IL- 11, ciliary 
neurotrophic factor (CNTF) and LIF [17,18]. 
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Most animal models of tumor growth, metastasis, ar- 
thritis or fibrosis have been established with mice or rats. 
Therefore we produced a polyclonal antiserum specific 
for murine TIMP-1 which cross reacts with rat TIMP-1 
but not with human TIMP-1. We show that the expres- 
sion of secreted TIMP-1 protein can be up-regulated by 
the cytokines IL-lp and IL-6. Taken together with our 
finding that TIMP-1 mRNA is induced during the acute 
phase reaction in liver cells, our results emphasize the 
involvement of TIMP-1 in liver fibrosis and cirrhosis. 
2. Materials and methods 
2. I. Reagents 
Restriction enzymes and PNGase F were obtained from Boehringer 
Mannheim (Mannheim, Germany). Tran[“S]label was purchased from 
ICN (Meckenheim, Germany), [a-“*P]dATP were from Amersham In- 
ternational (Amersham, GB) and pansorbin from Calbiochem (La 
Jolla, CA). DMEM was obtained from Gibco (Eggenstein, FRG) and 
FCS from Seromed (Berlin, Germany). The murine TIMP-I cDNA was 
a kind gift from Dr. D.R. Edwards (Calgary, Canada). The bacterial 
expression plasmid pRSET 5d and the host bacteria BL21 (DE3) were 
a gift from Dr. R. Schoepfer [19]. Recombinant Human IL-l/I with a 
specific activity of 2 x lo7 units/pg protein was a generous gift of Dr. 
A.R. Shaw (Glaxo Institut for Molecular Biology, Geneva, Switzer- 
land). Recombinant human IL-6 with a specific activity of 1.5 x lo6 
B-cell stimulatory factor 2 units/pg protein was generously supplied by 
Drs. T. Hirano and T. Kishimoto (Osaka, Japan). 
2.2. Cells and cell treatment 
COS-7 cells were cultured to 7&90% confluency in DMEM contain- 
ing 10% FCS streptomycin (100 mg/l) and penicillin (60 mg/l), at 5% 
CO, in a water-saturated atmosphere. Rat hepatocytes in primary cul- 
ture were prepared as described in [I 71 after perfusion of rat livers with 
collagenase. Hepatocytes were cultured serum-free for 48 h before the 
experiments. 
2.3. Construction of a bacterial TIMP-I expression plasmid 
Standard cloning procedures were performed as described in Sam- 
brook et al. [20]. A cDNA insert coding for murine TIMP-1 without 
signal peptide was constructed by polymerase chain reaction using the 
following primers: 5’-CCGGCCEGCCTGTAGCTGGCCCCA-3’, 
5’-TCATCGGGCCCCAAGGG-3’, thus replacing the signal peptide 
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with the start codon of translation (underlined). Finally the 540 bp 
BumHIIHindI11 fragment was inserted into the NcoIlHindIII site of the 
expression vector pRSET. All polymerase chain reaction-generated 
sequences were verified by DNA sequencing [21] using T7 DNA polym- 
erase (Pharmacia, Freiburg, Germany). 
2.4. Preparation of rabbit polyclonal anti-murine-TIMP-I 
A rabbit was immunized subcutaneously with 200 pg of recombinant 
murine TIMP-I emulsified with Freund’s complete adjuvant. Immuni- 
zations were made in Freund’s complete and incomplete adjuvant in 
4-week intervals for a total of three months. The antiserum called 
antiserum A was obtained IO days after the last injection. 
2.5. Western blots 
Supernatants were separated on 15% SDS polyacrylamide gel and 
transferred to nitrocellulose. Protein bands were localized by staining 
with Ponceau S. Blots were blocked with PBS, containing 2% BSA 
washed and incubated with the polyclonal antiserum against murine 
TIMP-I. After washing the blot was incubated with an anti-rabbit 
antibody (Serva). Immunocomplexes were visualized by peroxidase 
staining. 
2.6. Construction of a eucaryotic TIMP-I expression plasmid 
The mammalian TIMP-1 expression vector was constructed by in- 
serting the entire coding region of the murine TIMP-I exised from the 
Bluescript-vector KS- by the restriction endonucleases BamHIlXhoI 
and cloned into the XhoI and filled Hind111 site of the expression vector 
pCDM8. 
2.7. Transfection of mammalian cells 
Transfections were performed using the calcium phosphate technique 
[22]. COS-7-cells for transfection were subcultured I6 h prior to the 
addition of the calcium phosphate precipitate; I8 h after transfection 
the precipitate was removed and cells were cultured for 24 h. 
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Fig. 1. Bacterial expression of murine TIMP-I. (A) Construction of the bacterial murine TIMP-I expression vector: A cDNA insert coding for murine 
TIMP-I without signal peptide was constructed by polymerase chain reaction (as described in section 2) and inserted into the expression vector 
pRSET5d. (B) SDS-PAGE of proteins from bacteria transformed with the empty expression vector pRSET (lane l), the murine TIMP-1 vector before 
induction with IPTG (lane 2) and I pg (lane 3) and 5 pg (lane 4) inclusion bodies of the same cells. The arrow indicates the position of TIMP-I 
expressed by transformed bacteria. (C) Detection of murine TIMP-I inclusion bodies by Western blotting. 1 pg (lane 1) and 5 fig (lane 2) of inclusion 
bodies in lysis buffer were electrophoresed on a 13% SDS-polyacrylamide gel and analyzed by Western blotting using a polyclonal murine-TIMP- 
l-antiserum obtained as described in section 2. The arrow indicates the position of TIMP-I expressed by transformed bacteria. 
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2.8. Immunoprecipitation 
Cells were metabollically labeled with [35S]methionine/cysteine under 
the conditions indicated in the figure legends. Cell lysis was performed 
in 10 mM Tris-HCl, pH 7.4,60 mM EDTA, 1% Nonidet P40 and 0.4% 
sodium deoxycholate. Supernatants and lysates were pretreated with 
pansorbin (Calbiochem, La Jolla, CA) and subsequently incubated with 
the appropriate antisera for 3 h at 4°C. The immunocomplexes were 
precipitated with protein A-Sepharose, separated on a 15% SDS-poly- 
acrylamide gel [23] and visualized by fluorography [24]. Rat hepato- 
cytes in primary culture were stimulated 12 h before immunoprecipita- 
tion. 
2.9. Indirect immunojiuorescence 
Procedures for indirect immunofluorescence of transfected COS-7 
cells were done as described [25]. Cells grown on cover glasses for 
24 h were fixed with 0.2% paraformaldehyde and treated with a l/100 
dilution of an antiserum for 20 min. Detection of the antibodies bound 
to membrane proteins was carried out by treatment with a 11200 dilu- 
tion of a rhodamine-conjugated anti-rabbit IgG antibody for 20 min. 
Cover glasses were mounted on slides with Moviol 4-88 (Calbiochem, 
La Jolla, CA) and analyzed using fluorescence microscopy. A 200-fold 
magnification was used to photograph the cells. 
3. Results and discussion 
A cDNA coding for the murine TIMP-1 lacking the 
signal peptide (mTIMP-1) was cloned into the expression 
plasmid pRSET5d as described in section 2 (Fig. 1A). 
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Fig. 2. Detection of murine TIMP-1 protein. (A) Immunoprecipitation of murine TIMP-1 from supematants and cell lysates of transfected and 
non-transfected COS-7 cells with the polyclonal antiserum A. COS-7 (2 x 106) and COS-7-murine-TIMP-1 (2 x 10”) cells were labeled with 80 &i 
Tran[“S]label in methioninekysteine-free medium for 3 h. After 2 h of chasing supematants (SN; left side) and cell lysates (Cells; right side) were 
immunoprecipitated with murk-TIMP-l-antiserum A and analyzed by SDS-PAGE and fluorography. 100 ng of murine TIMP-1 expressed in 
E. coli was added as competitor before immunoprecipitation as indicated in the figure. Immunoprecipitated proteins were deglycosylated with PNGase 
F (2U/lOO~l) as indicated. (B) Immunofluorescence of transfected COS-7 cells transfected with murine TIMP-1 and untransfected COS-7 cells. Cells 
were stained with the polyclonal antiserum against murine TIMP-1 and a rhodamine-conjugated antirabbit IgG antibody. Magnification: x 200. 
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E. coli BL21 were transformed with this expression vec- 
tor, induced with IPTG and proteins solubilized from 
inclusion bodies were separated by SDS-PAGE and vis- 
ualized by silver staining (Fig. 1B). After induction with 
IPTG a protein of about 20-22 kDa is expressed (lane 
3 and 4). In the absence of IPTG no protein of the 
corresponding size could be detected (lane 2). The re- 
combinant protein was injected into rabbits and an antis- 
erum was obtained. Using this antiserum against murine 
TIMP-1 (see section 2) the inclusion bodies could be 
visualized by Western blot analysis (Fig. 1C). 
Human TIMP-1 protein from IL-6 stimulated human 
hepatoma cells (HepG2) [18] was not recognized by the 
antiserum A raised against the recombinant murine 
TIMP-1 protein, thus demonstrating that the murine 
TIMP-1 antiserum does not cross-react with human 
TIMP-1 protein (data not shown). 
To investigate the biosynthesis and glycosylation of 
native TIMP-1 protein immunoprecipitations of simian 
kidney cells (COS-7) transiently transfected with an ex- 
pression vector coding for murine TIMP-1 were carried 
out. Using the polyclonal antiserum A against murine 
TIMP-1 a 28-30 kDa protein was immunoprecipitated 
from supernatants and cell lysates of transfected COS-7 
cells metabollically labeled with [35S]cysteine/methionine 
(Fig. 2A). To show that the immunoprecipitation of 
murine TIMP-1 protein was specific, we performed com- 
petition experiments with non-radioactive labeled re- 
combinant TIMP-1 protein. Immunoprecipitation of 
TIMP-1 could be prevented by the addition of murine 
TIMP-1 expressed in E. coli as competitor (Fig. 2A). 
ular weight of the TIMP-1 expressed in bacterial and in 
mammalian cells we analyzed glycosylation of the mur- 
ine TIMP-1 protein. TIMP-1 from metabollically labeled 
transfected COS-7 cells was immunoprecipitated from 
cell lysates and media and treated with PNGase F as 
indicated in Fig. 2A. Upon treatment with PNGase F the 
mobility of the TIMP-1 protein shifted from 28-30 kDa 
to 20-22 kDa indicating that N-glycosylation is the pre- 
dominant post-translational modification of TIMP-1 ex- 
pressed in COS-7 cells. It is not clear so far which of the 
two N-glycosylation sites are used in the protein [27]. 
Interestingly TIMP-1 could also be detected in cell ly- 
sates even after a chase time of 2 h (Fig. 2A, right side). 
We conclude that the mature form of TIMP-1 is either 
not secreted or the secreted protein is partially deposited 
in the ECM of cells. We therefore chose to analyse the 
cellular distribution of murine TIMP-1 by indirect im- 
munofluorescence staining using the polyclonal antise- 
rum A. In studies with transfected COS-7 cells murine 
TIMP- 1 protein is detected on the surface of non-perme- 
abilized cells (Fig. 2B). Untransfected control cells 
showed no specific cell-associated TIMP-1 staining. It is 
therefore possible that newly synthesized TIMP-1 pro- 
tein associates with matrix proteinases. 
In order to explain the discrepancy in apparent molec- 
In order to observe the regulation of TIMP-1 in a 
more physiological system and since we already now that 
TIMP-1 mRNA is up-regulated in liver cells under acute 
phase conditions [17,18] we tried to immunoprecipitate 
TIMP-1 from stimulated rat hepatocytes. Rat hepato- 
cytes in primary culture were incubated 12 h with recom- 
binant human IL-lp, IL-6, or conditioned medium from 
human monocytes stimulated with LPS as indicated in 
rat hepatocytes 
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Fig. 3. Immunoprecipitation of TIMP-1 from supernatants of rat hepatocytes in primary cultures. Rat hepatocyte primary cultures (4 x IO6 cells per 
dish) were incubated in the presence of IL-IS, IL-6 and 1 ml of conditioned medium from LPS-stimulated human monocytes (1 &ml for 18 h) for 
12 h before labeling with 200 @Ci Tran[%]label in methioninekysteine-free medium for 3 h. After 2 h of chasing supernatants were immunoprecip- 
itated with murine-TIMP-l-antiserum A and analyzed by SDS-PAGE and fluorography. 100 ng of murine TIMP-I expressed in E. coli was added 
as competitor before immunoprecipitation as indicated in the figure. The arrow indicates the position of TIMP-1. 
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Fig. 3. The newly synthesized and secreted proteins were 
analyzed by SDS-polyacrylamide gel electrophoresis 
after immunoprecipitation with the antiserum A against 
murine TIMP- 1. As we could already show on mRNA 
level [ 171 TIMP- 1 protein is up-regulated after stimula- 
tion of liver cells with inflammatory cytokines. After 
addition of recombinant murine TIMP-1 as competitor 
(Fig. 3, lane 2) immunoprecipitation of rat TIMP-1 
could partly be prevented. Besides TIMP-1 a protein of 
100-l 50 kDa is detected by the antiserum A. These pro- 
teins might be matrix metalloproteinases tightly associ- 
ated with newly synthesized TIMP-1. Taken together 
with the finding that TIMP-1 is elevated in serum of 
patients with chronic liver diseases [27] TIMP-1 could 
possibly be involved in the pathogenesis of liver fibrosis. 
TIMP-1 has been identified in the culture medium of 
many connective tissue cells, explants, and in synovial 
fluids [28]. Its occurence has been implicated with tissue 
sclerosis and fibrosis [ 1,2,27]. So far, for the mouse or rat 
system no antisera have been described to detect the 
protein, With the antiserum described in this study it will 
be possible to detect local changes in TIMP-1 expression 
in murine and rat models for tumor metastasis, fibrosis 
or pathological tissue breakdown like arthritis. Progress 
in this area should help to elucidate the role of TIMP-I 
in the pathogenesis of these diseases and should indicate 
a route for rational strategies for the design of therapeu- 
tic compounds. 
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